- ChineseInvestors.com
is a leading financial information website for Chinese-speaking investors
- The
company reported a 175 percent year-over-year increase in revenue for
FY2019
- CIIX’s
CBD Biotech Inc. division recently launched six new skincare products
ChineseInvestors.com Inc. (OTCQB: CIIX) is a foremost
financial information website for Chinese-speaking investors in the United
States and China. In addition, via its CBD division (CBD Biotech Inc.), the
company was focusing on cannabidiol (CBD)-based nutrition and health products.
However, the company’s current plan is to return focus to its original mission
of providing financial information and services to the larger Chinese community
in the United States and elsewhere. Established in 1999, ChineseInvestors.com
is based in San Gabriel, California (http://ibn.fm/R3ymn), and it has been operating its premier
financial information website for 18 years.
CIIX offers an array of investor education products and
services on its main website, www.ChineseInvestors.com. The company provides real-time
market commentary, analysis and education-related services in Chinese language
character sets, including both traditional and simplified. The company also
offers its proprietary ChineseInvestors Method, an innovative integration of a
disciplined investing process, web-based tools, personalized instructions and
support. Therefore, CIIX provides reliable market information to help investors
make informed investment decisions and meet their individualized financial
goals.
Moreover, CIIX provides consultative services to smaller
private businesses that are considering going public. The company also provides
advertising and public relations-related support services. Additionally, CIIX
raises awareness through investor conferences and road shows.
Recently, CIIX provided an update on its financial results
for the fiscal year ended May 31, 2019, as well as an outlook for fiscal year
2020 (http://ibn.fm/AO8WR).
The company reported a 175 percent year-over-year increase in revenue for
FY2019, with $4,189,935 in sales revenue from industrial hemp and CBD liquor
products in FY2019. This number is up from $378,984 in FY2018.
Furthermore, CIIX reported $1,336,402 in investor relations
revenues in FY2019, up from $968,282 in FY2018. The company’s subscription
revenue in FY2019 was $865,457, up from $779,964 in FY2018. The majority (95
percent) of CIIX’s subscriber base (free and paid members) is located in the
United States and Canada. The company’s services are generally delivered to
U.S. public and private businesses and also U.S. residents and citizens (http://ibn.fm/WW00f).
“While we have been strategically focusing on industrial
hemp and CBD sales, we are pleased with the progress we have seen in our legacy
businesses, financial news, education subscriptions, and investor relations,
where we are re-focused on organic growth,” CIIX CEO Warren Wang stated in a
news release. “We expect to see the full result of these efforts in FY2020.”
Wang also noted that CIIX hopes for a Nasdaq IPO of CBD
Biotech late in FY2019 or early next year. CIIX would then concentrate on
identifying an acquisition target for further growth (http://ibn.fm/WPOqV).
In addition, CIIX recently announced that CBD Biotech
launched six new products in combination with its long-term strategic plans to
expand its hemp/CBD skincare offerings. CBD Biotech’s new products include CBD
Oligopeptides Repair Eye Cream, CBD Nerve Acylamide Eye Essence, CBD Hemp Eye
Mask, CBD Gold Nicotinamide Essence, CBD Handmade Horse Oil Soap and CBD Clear
Bright. These products are designed to complement the company’s present
skincare lines and increase brand loyalty and awareness.
CIIX is re-focusing on its legacy business of providing
first-rate financial information and services to the larger Chinese community.
Of note for investors is that the company anticipates doubling its sales over
the next 12 months. CIIX continues to execute on its strategy of solidifying
its position as the leading financial information website for Chinese-speaking
investors in the U.S. and China.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates
relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
